Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -39.76% is 45% above its 3-year average of -72.46%, near the high end of its 3-year range (-191.80%–-37.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 33.65% above its 12-month average of -59.93%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -39.76%.
RETURN ON INVESTED CAPITAL (ROIC)
-39.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-59.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-70.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+33.65%
CURRENT VS 3Y AVG
+43.24%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 730 covered companies
CURRENT VS SECTOR MEDIAN
-19.11%
vs the sector median at left
Lexeo Therapeutics, Inc. Common Stock
Market Cap
$263.05M
Return on Invested Capital (ROIC)
-39.76%
TTM Avg
-59.93%
3Y Avg
-70.06%
5Y Avg
N/A
Market Cap
$261.24M
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-103.16%
3Y Avg
-110.30%
5Y Avg
-171.09%
Market Cap
$261.05M
Return on Invested Capital (ROIC)
-89.43%
TTM Avg
-77.88%
3Y Avg
-57.02%
5Y Avg
-48.01%
Market Cap
$265.31M
Return on Invested Capital (ROIC)
-43.56%
TTM Avg
-66.27%
3Y Avg
-114.94%
5Y Avg
-104.61%
Market Cap
$266.05M
Return on Invested Capital (ROIC)
-42.92%
TTM Avg
-30.10%
3Y Avg
-80.25%
5Y Avg
-64.52%
Market Cap
$266.44M
Return on Invested Capital (ROIC)
-15.00%
TTM Avg
-11.69%
3Y Avg
-3.29%
5Y Avg
-2.92%
Market Cap
$267.03M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-56.97%
3Y Avg
-50.85%
5Y Avg
-45.83%
Market Cap
$258.43M
Return on Invested Capital (ROIC)
-3.17%
TTM Avg
-4.70%
3Y Avg
-2.14%
5Y Avg
-2.73%
Market Cap
$272.42M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. Common Stock (LXEO) | $263.05M | -39.76% | -59.93% | -70.06% | N/A |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | -28.96% | -103.16% | -110.30% | -171.09% |
| AC Immune S.A. (ACIU)vs › | $261.05M | -89.43% | -77.88% | -57.02% | -48.01% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $265.31M | -43.56% | -66.27% | -114.94% | -104.61% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $266.05M | -42.92% | -30.10% | -80.25% | -64.52% |
| OraSure Technologies, Inc. (OSUR)vs › | $266.44M | -15.00% | -11.69% | -3.29% | -2.92% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | -170.19% | -56.97% | -50.85% | -45.83% |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.43M | -3.17% | -4.70% | -2.14% | -2.73% |
| Scribe Therapeutics Inc. (SCTX)vs › | $272.42M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $274.22M | -48.92% | -66.11% | -56.53% | -47.58% |
ROIC
-39.8%
ROE
-37.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -39.76% |
| 2026-03-31 | -41.41% |
| 2025-12-31 | -43.38% |
| 2025-09-30 | -89.69% |
| 2025-06-30 | -85.43% |
| 2025-03-31 | -122.57% |
| 2024-12-31 | -85.23% |
| 2024-09-30 | -63.49% |
| 2024-06-30 | -47.41% |
| 2024-03-31 | -37.85% |
| 2023-12-31 | -55.90% |
| 2023-09-30 | -191.80% |
| 2023-06-30 | -128.60% |
| 2023-03-31 | -100.59% |
| 2022-12-31 | -73.14% |
